Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy
Authors:
- Josep JulveJosep Julve
- Joana RossellJRJoana Rossell
- Eudald CorreigECEudald Correig
- Marina Idalia Rojo-LopezMarina Idalia Rojo-Lopez
- Nuria AmigóNANuria Amigó
- Marta HernándezMHMarta Hernández
- Alicia TravesetATAlicia Traveset
- Marc CarbonellMCMarc Carbonell
- Nuria AlonsoNANuria Alonso
- Didac MauricioDidac Mauricio
- Esmeralda CastelblancoECEsmeralda Castelblanco
Open Access
- 22 September 2022
- Vol. 14 (19) , 3932
Abstract
This study aimed to assess whether the advanced characteristics of serum lipoprotein subclasses could better predict the risk of developing diabetic retinopathy (DR) and its severity compared to other established risk factors in subjects with type 1 (T1D) and type 2 (T2D) diabetes. This observational, cross-sectional substudy analyzed DR-related data from 309 T1D and 264 T2D subjects. The advanced lipoprotein and glycoprotein profile was determined by nuclear magnetic resonance (NMR) spectroscopy (Liposcale test). NMR analysis of lipoproteins revealed that T1D subjects with DR showed standard non-HDL particles, despite higher IDL lipid concentrations. Notably, IDL lipids were elevated in T1D subjects with worsened DR. VLDL and LDL were smaller, whereas HDL triglycerides were increased in DR compared with non-DR. On the other hand, the T2D subjects with DR showed altered characteristics in the LDL fraction, mainly revealed by a significant decrease in smaller LDL and a reduction in LDL-C. Moreover, the glycoprotein profile did not reveal significant changes among DR groups, regardless of the type of diabetes. However, lipoprotein characteristics and glycoproteins unveiled by NMR analysis did not improve the predictive value of conventional lipids or other traditional, well-established biomarkers of DR in our cohorts.Keywords
Funding Information
- Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain) (PI15/0625, PI17/01362, PI17/00232)
- FEDER “Una manera de hacer Europa,”
- Fundació La Marató de TV3 2016 (303/C/2016)
- CIBER-Consorcio Centro de Investigación Biomédica en Red-CIBERDEM (CB15/00071)
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
This publication has 60 references indexed in Scilit:
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD studyBMJ Evidence-Based Medicine, 2011
- Prevalence and Relationship Between Diabetic Retinopathy and Nephropathy, and its Risk Factors in the North-East of Spain, a Population-Based StudyOphthalmic Epidemiology, 2010
- Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degenerationJournal of Lipid Research, 2010
- Quantitative Assessment of Early Diabetic Retinopathy Using Fractal AnalysisDiabetes Care, 2009
- Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implicationsDiabetes, Obesity and Metabolism, 2007
- Associations Between Retinal Microvascular Abnormalities and Declining Renal Function in the Elderly Population: The Cardiovascular Health StudyAmerican Journal of Kidney Diseases, 2005
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003
- Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic controlActa Ophthalmologica Scandinavica, 1996
- Glycemic control, incipient diabetic nephropathy, and diabetic retinopathyJournal of Diabetic Complications, 1990